Clinical Trials Directory

Trials / Completed

CompletedNCT02328313

Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older

LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
134 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
65 Years
Healthy volunteers
Not accepted

Summary

To determine if exercise will affect the increase in p16 expression that is associated with both chemotherapy administration and advancing age.

Detailed description

LCCC1410 is designed to compare the change in p16 from baseline to end of chemotherapy in 100 older (≥ 65 years) breast cancer patients participating in a home-based physical activity program (intervention group) to 100 patients in the concurrent control group not participating in a physical activity intervention (enrolled in a separate RO1 study as described in section 1.7). The biomarker p16 is known to dramatically increase with chemotherapy, and we hypothesize that the increase will be attenuated by a physical activity intervention. We will evaluate changes in p16 between the two study populations. Data from the geriatric assessment at baseline will be used to characterize the study population, and subscale scores from the GA will also be assessed for differences between baseline and end of chemotherapy to compare the LCCC1410 study population with the concurrent control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWalk with Ease ProgramThe Walk With Ease Program sets a goal for participants to walk 30 minutes a day five times a week and gives helpful hints on how to achieve this goal.

Timeline

Start date
2014-10-01
Primary completion
2019-01-16
Completion
2019-01-16
First posted
2014-12-31
Last updated
2020-04-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02328313. Inclusion in this directory is not an endorsement.